Table_1_N-Palmitoylethanolamine Supplementation for Long-Lasting, Low-Dosed Morphine Antinociception.doc by Lorenzo Di Cesare Mannelli (600627)

“…The same pain threshold increase was achieved in animals using preemptive PEA (30 mg/kg, daily) joined to a combinatorial acute treatment with morphine (5–20 mg/kg s.c.) and PEA (30–120 mg/kg, p.o.). …”

Table_3_N-Palmitoylethanolamine Supplementation for Long-Lasting, Low-Dosed Morphine Antinociception.DOC by Lorenzo Di Cesare Mannelli (600627)

“…The same pain threshold increase was achieved in animals using preemptive PEA (30 mg/kg, daily) joined to a combinatorial acute treatment with morphine (5–20 mg/kg s.c.) and PEA (30–120 mg/kg, p.o.). …”

Image_2_N-Palmitoylethanolamine Supplementation for Long-Lasting, Low-Dosed Morphine Antinociception.TIF by Lorenzo Di Cesare Mannelli (600627)

“…The same pain threshold increase was achieved in animals using preemptive PEA (30 mg/kg, daily) joined to a combinatorial acute treatment with morphine (5–20 mg/kg s.c.) and PEA (30–120 mg/kg, p.o.). …”

Image_2_Ultramicronized N-Palmitoylethanolamine Supplementation for Long-Lasting, Low-Dosed Morphine Antinociception.TIF by Lorenzo Di Cesare Mannelli (600627)

“…The same pain threshold increase was achieved in animals using preemptive PEA (30 mg/kg, daily) joined to a combinatorial acute treatment with morphine (5–20 mg/kg s.c.) and PEA (30–120 mg/kg, p.o.). …”

Creasable Batteries: Understanding Failure Modes through Dynamic Electrochemical Mechanical Testing by Aaron J. Blake (1443796)

“…The results show that mechanically robust and flexible Li-ion batteries (Li₄Ti₅O₁₂//LiFePO₄) based on the use of a nonwoven multiwalled carbon nanotube (MWNT) mat as a current collector (CC) exhibited a 14-fold decrease in voltage fluctuation at a bending strain of 4.2%, as compared to cells using traditional metal foil CCs. …”

Color space representation across different CNN layers and different CNN architectures. by JohnMark Taylor (8329326)

“…In the second scenario, the color space structure for each object remains relatively stable across processing, resulting in a relatively small decrease in correlation across layers. b. …”

Lipreading fMRI study by Julio Plata-Bello (7430603)

Additional file 1 of MDM2-amplified esophageal adenocarcinomas exhibit an activated metabolic and immunosuppressive phenotype with multiple potential therapeutic targets by Karl Knipper (15016346)

“…This table contains the processed protein expression data and the test results of the ANOVA and Welch`s T-test investigating the difference of the proteome of neoadjuvantly treated MDM2-amplified versus non-amplified tumors. Each row contains a unique protein. Supplementary Table 5. Test results of the enrichment analyses using the pathway annotation Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway name, Gene Ontology Biological Process (GOBP) name, and Reactome name encyclopedia comparing neoadjuvantly treated MDM2-amplified tumors with non-amplified tumors. …”

MTG16 inhibition of <i>PFKFB3, PFKFB4</i> and <i>PDK1</i> during hypoxia. by Parveen Kumar (428921)

Fumagillin and Silencing of MetAP2 Expression Inhibit Proliferation of RPASMC <i>in vitro</i>. by Daniel J. Kass (173086)

“…Cells were then released from G0 by addition of 10% FBS supplemented with or without PDGF (10 ng/mL) or fumagillin (20 nM). Cells were fixed after 0, 1, 2, and 3 days of culture and then stained with SYBR Green as described in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0035388#s2" target="_blank">Materials and Methods</a>. …”

DataSheet1_Magnesium-Assisted Cisplatin Inhibits Bladder Cancer Cell Survival by Modulating Wnt/β-Catenin Signaling Pathway.pdf by Tianye Li (9759056)

“…Most importantly, a marked decrease in nuclear β-catenin was observed in cells that received cisplatin treatment. …”

Hypotonic-mediated [Ca²⁺]_i signals require Ca²⁺ influx via TRPC3 in CD cells. by Viktor N. Tomilin (8150094)

“…<p>(<b>A)</b> The average time course of [Ca²⁺]_i changes in response to 10X elevations in perfusion rate from 1.5 ml/min to 15 ml/min (high flow) and application of hypotonic medium (220 mOsm) in the absence and in the presence of a TRPV4 inhibitor, ruthenium red (RuR, 1 μM) in individual CD cells within split-opened area. …”

Table1_Magnesium-Assisted Cisplatin Inhibits Bladder Cancer Cell Survival by Modulating Wnt/β-Catenin Signaling Pathway.PDF by Tianye Li (9759056)

“…Most importantly, a marked decrease in nuclear β-catenin was observed in cells that received cisplatin treatment. …”

Increased CN inhibition leads to reduced STO frequency and to more CSpk frequency. by Elías M. Fernández Santoro (22470299)

“…<p>(A) After Plasticity difference for SSpks is significant across coupled cases for the Upbound zone (t = 4.51, p < 0.001; two-sample Student’s t-test; n = 100) and for coupled case across zones (t = -5.36, p < 0.001; two-sample Student’s t-test; n = 100). …”

Molecular Response of Pulp Fibroblasts after Stimulation with Pulp Capping Materials by Karin Cristina da Silva Modena (4791021)

“…The specimens were prepared under sterile conditions and in disks measuring 5 mm x 2 mm obtained from a prefabricated mold and placed on a permeable membrane to avoid direct contact with the cells. …”

Lipid binding profiles of PDZ domains and differential effects of peptide ligands on PtdInsPs binding. by Ylva Ivarsson (279161)

“…<p><b>A</b>. Apparent PDZ-PtdInsPs affinities as determined by SPR equilibrium binding experiments between his-tagged PDZ domains and 5% PtdInsPs (DOPC liposomes). …”

STAD-2 reduces viability of <i>P</i>. <i>falciparum in vitro</i>. by Briana R. Flaherty (744995)

“…<p>(<b>A</b>) Synchronous ring- or late-stage iRBC were treated with 0, 0.5, 1, 2, or 5 μM STAD-2 or its scramble control, and parasitemia was determined by flow cytometry at 24-hours post-treatment. …”

DataSheet3_Neuroprotective effects of Neurotrophin-3 in MPTP-induced zebrafish Parkinson’s disease model.PDF by Noor Azzizah Omar (16880058)

“…<p>Introduction: Neurotrophin-3 (NT3) is a neuroprotective growth factor that induces the development, maintenance and survival of neurons. …”

DataSheet2_Neuroprotective effects of Neurotrophin-3 in MPTP-induced zebrafish Parkinson’s disease model.PDF by Noor Azzizah Omar (16880058)

“…<p>Introduction: Neurotrophin-3 (NT3) is a neuroprotective growth factor that induces the development, maintenance and survival of neurons. …”

DataSheet1_Neuroprotective effects of Neurotrophin-3 in MPTP-induced zebrafish Parkinson’s disease model.PDF by Noor Azzizah Omar (16880058)

“…<p>Introduction: Neurotrophin-3 (NT3) is a neuroprotective growth factor that induces the development, maintenance and survival of neurons. …”